Pure Global
NCT02845739

PApillomavirus in REnal Transplant Patient

Study of the Distribution of Genotypes of HPV at the Ano-genital Area and Peripheral Humoral Immune Response Before and After Kidney Transplantation
Centre Hospitalier Universitaire de Besancon·ClinicalTrials.gov·otherCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Papillomavirus Infections
Drug/Device/Intervention
Kidney transplanted patients
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Centre Hospitalier Universitaire de Besancon
Timeline & enrollment
Phase
N/A
Start date
Jan 01, 2011
End date
Nov 10, 2017
Enrollment
58 participants
Primary outcome

Prevalence of genital HPV infection before and after kidney transplantation in man and women

Summary

The main goal of project is to study the distribution of HPV genotypes in the anogenital area
 and peripheral humoral immune responses HPV (total and neutralizing Ab) before and after
 renal transplantation. Furthermore, the investigators wish (i) establish whether there is a
 correlation between HPV infection and HPV immune response before and after transplantation,
 and (ii) determine whether there is a link between HPV infection and immunosuppression.

ICD-10 classifications
Papillomavirus as the cause of diseases classified to other chaptersPapovavirus infection, unspecified sitePapilloedema, unspecifiedViral infection, unspecifiedParvovirus as the cause of diseases classified to other chapters
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT02845739
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT02845739 through Pure Global AI's free database. This phase not specified trial is sponsored by Centre Hospitalier Universitaire de Besancon and is currently Completed. The study focuses on Papillomavirus Infections. Target enrollment is 58 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.